Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
To improve the treatment of hepatotoxic responses to antituberculosis polychemotherapy, the impact of remaxol on the biochemical indices and parameters of the antioxidant system in patients with tuberculosis and HIV infection was estimated. The use of remaxol having cytoprotective, anticholestatic,...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Russo |
| Опубликовано: |
LLC "Publishing House OKI"
2020-05-01
|
| Серии: | Антибиотики и Химиотерапия |
| Предметы: | |
| Online-ссылка: | https://www.antibiotics-chemotherapy.ru/jour/article/view/446 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|